FEMSelect

Israel-based FEMSelect is the developer of EnPlace, the FDA cleared and CE Marked system for suturing ligaments of the pelvic floor as an approach to minimally-invasive Pelvic Organ Prolapse (POP) procedures. The EnPlace approach is much simpler to perform and much easier to recover from - than the current standard of care dissection approach. The Problem: Pelvic Organ Prolapse (POP) is a painful, debilitating medical condition that occurs when the normal support of the vagina is lost, resulting in the sagging or dropping of the female pelvic organs. POP is a very common and bothersome condition facing many women. The Unmet Need: A Simple and Safe Pelvic Floor Repair System. The current standard of care includes hysterectomy or complicated mesh surgery. Mesh has been associated with pain, bleeding and other complications. In 2011, the FDA issued warnings regarding transvaginal mesh and many products were withdrawn from the market, leaving few good options. Many women believe th...